1. Home
  2. UL vs SNY Comparison

UL vs SNY Comparison

Compare UL & SNY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Unilever PLC

UL

Unilever PLC

HOLD

Current Price

$60.60

Market Cap

125.1B

ML Signal

HOLD

Logo Sanofi ADS

SNY

Sanofi ADS

HOLD

Current Price

$42.34

Market Cap

104.5B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
UL
SNY
Founded
1930
1994
Country
United Kingdom
France
Employees
96092
74846
Industry
Package Goods/Cosmetics
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
125.1B
104.5B
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
UL
SNY
Price
$60.60
$42.34
Analyst Decision
Buy
Analyst Count
0
5
Target Price
N/A
$58.00
AVG Volume (30 Days)
4.1M
3.5M
Earning Date
03-12-2026
04-23-2026
Dividend Yield
4.04%
3.47%
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$2.53
$3.49
Revenue Next Year
$3.78
$6.10
P/E Ratio
$14.29
$6.14
Revenue Growth
N/A
N/A
52 Week Low
$54.75
$40.89
52 Week High
$74.98
$52.68

Technical Indicators

Market Signals
Indicator
UL
SNY
Relative Strength Index (RSI) 62.46 43.39
Support Level $60.16 $42.30
Resistance Level $61.14 $48.76
Average True Range (ATR) 0.78 0.73
MACD 0.36 -0.15
Stochastic Oscillator 89.92 35.86

Price Performance

Historical Comparison
UL
SNY

About UL Unilever PLC

Unilever is a diversified beauty, wellbeing, and personal care (51% of 2025 sales by value), homecare (23%), and packaged food (26%) company. Its brands include Dove personal-care products, Knorr soups and sauces, Hellmann's mayonnaise, Axe and Rexona deodorants, and TRESemmé haircare. The firm has been acquisitive in recent years; notable purchases include Paula's Choice, Liquid I.V., Horlicks, and Wild deodorants. The company derives 58% of its sales from emerging markets and 42% from developed markets. The US is its largest market, accounting for around 20% of sales, followed by India, which accounts for 11% of sales.

About SNY Sanofi ADS

Sanofi develops and markets drugs with a concentration in immunology, vaccines, and rare diseases. Although the company offers a diverse array of drugs, its highest revenue generator, Dupixent, accounts for over 30% of total sales. Profits for this immunology blockbuster drug are shared with Regeneron. About 45% of total revenue comes from the United States, 20% from Europe, and 6% from China.

Share on Social Networks: